Introduction Restorative proctocolectomy has gained acceptance in the surgical management of medically refractive ulcerative colitis and cancer prevention in familial adenomatous polyposis. Incontinence following restorative proctocolectomy occurs in up to 25% of patients overnight. The Renew â insert is an inert single-
Introduction
The treatment of anal incontinence remains challenging. It has significant social and economic implications and can have a significant effect on a patient's quality of life [1] [2] [3] . It is likely that the prevalence of faecal incontinence is underestimated due to patients' reluctance to report it [4] .
Restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis (IPAA) was pioneered by Parks and Nicholls in 1978 [5] . It has gained acceptance in the surgical management of medically refractive ulcerative colitis and cancer prevention in familial adenomatous polyposis.
Incontinence following RPC has not been widely researched. In one study, at 10-year follow-up continence for stool and gas was present in 79.3% of patients, with 74.4% being fully continent overnight. Incontinence following RPC can be multifactorial and can be related to inflammation of the pouch (pouchitis), inflammation of the cuff (cuffitis), chronic sepsis or weakness of the anal sphincter. Despite attempts to treat the underlying cause, incontinence may remain a problem and symptomatic control may be necessary.
Treatment of faecal incontinence can include conservative approaches, such as lifestyle modifications and dietary manipulation, medications such as antidiarrhoeal agents and barrier creams, physical and psychological therapies such as exercise and biofeedback, and surgery [6] .
The Renew â anal insert (Renew Medical Inc., Foster City, California, USA) is an inert single-use silicon device which acts as an anal plug (Fig. 1) . It is selfinserted using a removable applicator. The device is inserted into the anus where it acts as a seal. It is then expelled during normal defaecation, but can also be manually removed by pulling on the ring disc at the bottom of the applicator. The device costs £2.60 per insert and is freely available on the National Health Service. The device has been shown to be successful in 78% of patients with incontinence associated with a normal bowel, with 78% of patients being satisfied with the device [7] . To our knowledge, this is the first study to assess the acceptability, effectiveness and safety of the Renew â anal insert in patients who have undergone RPC.
Method
This was a prospective study exploring the acceptability, effectiveness and safety of the Renew â anal insert in controlling and improving incontinence in patients who had undergone RPC. This was a single-centre study at a specialist centre. Patients were identified through the hospital's biofeedback colorectal and inflammatory bowel clinics as well as through local pouch nurses. Patients were included if they had undergone RPC for any reason and had self-reported passive incontinence for more than 2 weeks and were aged 18 years or older at time of enrolment. Baseline clinical parameters were collected, including age, reason for RPC and other treatments given for passive faecal incontinence. Patients with active inflammation or undergoing treatment for pouch Step 1. Wash your hands. Separate a single blister unit by pulling sideways to break the perforations holding them together.
Step 2. Do not use a Renew Insert package unless it is fully sealed. Peel back the top of the package to fully expose the Renew Insert. Step 3. Place your index finger into the light blue removable applicator and lift the Renew Insert out of its package. The Renew Insert is now ready to use. If the Insert falls off the applicator prior to insertion, discard it and use a new one.
Step 4. Sit on a toilet. Raise yourself up onto one hip by leaning to the side. Reach behind your raised side and position the top disc of the Renew Insert so it's lightly resting on the anus.
Step 5. Relax your muscles and gently slide the Renew Insert into the anus until you feel the applicator touch the anus.
Step 6. Gently withdraw the applicator. The bottom disc of the Renew Insert should be resting just outside the anus.
Step 7. Discard the applicator in a waste receptacle. Wash your hands after use. The Renew Insert is now properly in place and sealing from the inside to help prevent ABL.
Step 9. For optimal protection, use a new Renew Insert after each bowel movement. Following completion of the study, patients were asked to record the acceptability and perceived effectiveness of the Renewâ anal insert device based on a threepoint scale: satisfied, neither satisfied nor dissatisfied, and dissatisfied. Patients were also encouraged to report any safety concerns regarding the device. Anti-diarrhoeal medications were allowed to be continued at the same dose prior to entering the trial.
We analysed the results as an intention-to-treat analysis. If patients did not complete the trial or were lost to follow-up we assumed that their ICIQ-B scores did not change from their baseline and that they were overall dissatisfied with the device and dissatisfied with the effectiveness. Change in the ICIQ-B was calculated by subtracting the average pretreatment score from the posttreatment score.
Statistical analysis
The Wilcoxon signed rank test was used to compare the pre-and postintervention scores. Statistical significance was defined as P-value < 0.05. Statistical tests were performed using SPSS version 24, (IBM Corporation, Armonk, New York, USA).
Interventions
The ICIQ-B is a validated questionnaire for faecal incontinence. It is split into four domains to separately measure bowel pattern, bowel control, quality of life and questions that are not directly scored but taken into account. It is a psychometrically robust, selfreport instrument that evaluates anal incontinence and its impact on quality of life [8] . The ICIQ-B is measured on an inverse scale (the lower the score, the better the function).
All patients recruited were also invited to undergo routine endoanal ultrasound scan (EAUS) and anal manometric testing in order to obtain objective measurements of sphincter structure and function. 
Results
Fifteen patients were included in the study (ten men and five women). All 15 patients had undergone RPC for ulcerative colitis. The median age of the patients was 57 years (range 24-74). The median time from restoration of continuity to starting the trial was 10.5 years (range 2-36). Five patients had a hand-sewn anastomosis, four had a stapled anastomosis and information was unavailable for nine patients. One patient had a redo pouch for a long rectal cuff and two patients had a pelvic abscess following restoration of continuity, both being treated with drainage and antibiotics at the time. During the trial, six patients continued to use stable doses of loperamide and one continued cholestyramine. One patient was lost to follow-up.
A comparison of the pre-and postintervention scores was made and the results are summarized in Table 1 .
The results suggest that there is no statistically significant difference between pre-and postintervention scores for the majority of the outcomes. The exception was for night seepage, where the values were significantly lower postintervention compared with preintervention.
Eight patients were satisfied with the acceptability of the Renew â device, two were neither satisfied nor dissatisfied and four were dissatisfied with the results (Fig. 2) . Six patients were satisfied with the effectiveness of the device, two were neither satisfied nor dissatisfied with the effectiveness of the device and six were dissatisfied with the effectiveness of the device (Fig. 3) .
Safety of the Renew â â â anal insert
One patient reported some contact bleeding on insertion of the device and one patient reported pain on insertion of the device. Both these patients were dissatisfied with the acceptability and effectiveness of the device and did not complete the full 14 days of the trial. They were analysed on an intention-to-treat basis. There were no other safety concerns or side effects reported.
Manometry results using Anopress
Manometry was performed in ten patients. Four declined the test and one was lost to follow-up. Manometry showed low pressures in most of the patients. The median resting pressure was 22.5 (20-73) mmHg. The median maximum squeeze increment was 97 (60-223) mmHg. The median endurance squeeze over 10 s was 53 (8-105) mmHg. The median for involuntary maximum squeeze was 96 (35-141) mmHg (Tables 2  and 3 ).
(Normal values can be found in Leo et al. [9] .) EAUS was performed in eight patients. Seven patients did not attend the clinic or declined to have the test. Four patients had degeneration or defects in the internal anal sphincter that contributed to their incontinence.
Discussion
Our study has shown that the Renew â anal insert can be a useful adjunct in the treatment of faecal incontinence in patients who have undergone RPC; it is associated with a significant reduction in night seepage. The Bold values represent statistically significant events.
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Acceptability score device was acceptable to 8/15 (53%) of patients and showed effectiveness in 6/15 (40%) of patients. There were no safety concerns reported in 13/15 (87%) of patients who used the device, and those that were reported were minor. Despite not reaching significance, the Renew â anal insert was associated with a trend towards improvement in bowel control, bowel pattern and daytime seepage. Anal manometry tests confirmed low resting pressures in most of the patients. Some patients also had degeneration of the internal sphincter which may have contributed to the symptoms. Interestingly, a small case series that followed up women with and without sphincter defects before and after RPC found that a sphincter defect was not predictive of long-term incontinence [10] . Our study suggests that patients with intact sphincters and patients with damaged sphincters suffer with incontinence following RPC, and that patients with intact external and internal sphincters are more likely to respond well to the Renew â anal insert.
Normal pressures following RPC have yet to be established; however, a study of 12 patients showed that patients with an ileoanal pouch had no significant differences in resting anal pressures compared with healthy controls [11] , suggesting that resting pressures are not altered following RPC. This is further supported by another study which suggested that there was no significant difference in anal manometry readings in patients with a colonic j-pouch and a coloplasty pouch [12] .
However, this must be interpreted with caution in the absence of validated normal manometry readings in patients following RPC.
Previous studies have shown limited benefit in the use of Coloplast anal plugs as they have been reported to be poorly tolerated by patients and difficult to use [13, 14] . It has been suggested that a major reason for this is the size of the plugs [7] . The Renew â insert is designed to fit the contours of the anus and is made of soft silicon, so may provide more comfort to patients with incontinence compared with standard anal plugs. Faecal incontinence in patients with an ileoanal pouch is reported as much more common than in the general population. It has been reported that 12 months following RPC 19% of patients suffered with occasional daytime incontinence and 49% suffered with nocturnal incontinence [15] . The reason for such a high rate of night-time incontinence is probably due to the sphincter muscles relaxing at night. Our study has suggested that the Renew â anal insert can be particularly helpful with night-time incontinence. The limitations of this study include the small sample size. As this was a pilot study a larger scaled study is needed, and power calculations could be based on the results documented here. Furthermore, one patient was lost to follow-up. We analysed the results as an intention-to-treat analysis which could have influenced the results. Further larger studies should validate these findings and may be able to risk stratify those patients who may benefit from using the device based on baseline characteristics, physiology and other investigations. Future studies should also help to define normal manometry and EAUS results in patients with a pouch to help assess normal and diseased states.
Conclusion
In a small series, the Renew â anal insert can be considered as a treatment that can help with faecal incontinence in patients who have undergone RPC. The Renew â anal insert was found to be acceptable in just over half of patients and effective in just under half of patients. Importantly, the device was associated with few safety concerns and significant reductions in night-time seepage.
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